Displaying 2801-2850 of 79847 result(s).
Recent Articles
- Sampo plc's Latest Share Buyback Program Overview
- Endeavour Mining's Strategic Share Buyback and Future Goals
- DEMIRE's Updated 2025 Forecast and Future Prospects Overview
- Nilfisk Q2 2025 Report: Positive Moves Amid Market Challenges
- Netcompany Reports Strong Results and Future Outlook
- Netcompany Group A/S Initiates Share Buyback Program
- Insights into Marimekko's 2026 Financial Reporting and AGM
- Seth Klarman's Baupost Group Expands Stakes in Key Stocks
- Aerodrome Finance Soars After CoinBase Integration Boost
- DEMIRE Updates Financial Forecast and Highlights Growth Plans
- Netcompany Reports Strong Financial Growth for H1 2025
- Nilfisk's Q2 2025 Results: Strategic Steps and Financial Trends
- Max Stock Limited Unveils Exciting New Cash Dividend Announcement
- Hexagon Composites ASA Reports Its Q2 Performance
- Navamedic ASA Reports Strong Revenue Growth in Q2 2025
- Fingerprint Cards AB Shows Significant Revenue Growth in 2025
- NORBIT Achieves Impressive Growth in Latest Financial Results
- Zealand Pharma's H1 2025 Results Showcase Promising Growth
- Marimekko Corporation Reports Growth in Q2 2025 Financials
- Max Stock Limited Announces Strong Q2 and First Half Performance
- Bioretec Ltd Reports on Growth and Strategic Developments
- Bioretec Ltd Reports Promising Growth Trends Ahead in 2025
- Bioretec Ltd Reports Positive Progress for Future Growth
- Innovative Breakthroughs in Thorium Fuel Technology by CCTE
- Kuros Biosciences Achieves Milestones in 2025 Half-Year Results
- Marimekko's Insights on Upcoming Financial Events and Meetings
- Basilea's Innovative Antibiotic Acquisition to Combat UTIs
- NORBIT Achieves Impressive Growth in Q2 2025 Performance
- Kaldvík AS Announces Leadership Change with New Interim CEO
- Marimekko Corporation's Mid-Year Report: Sales and Growth Insights
- Zealand Pharma's H1 2025: Growth and Strategic Developments
- Fingerprint Cards AB Reports Strong Interim Growth in 2025
- Sanofi's Rilzabrutinib Receives EU Orphan Designation for Rare Disease
- Construction Begins for Nõmme Südamekodu Elderly Care Facility
- Bigbank AS Celebrates Record Growth and Strong Financial Results
- Kaldvík AS Welcomes New Interim CEO for Future Growth
- Sanofi's Rilzabrutinib Secures Orphan Drug Status in Europe
- BRI Expands Financial Services for Indonesian Workers in Taiwan
- Max Stock Limited Reveals Impressive Financial Results
- Perplexity AI's Comet: Transforming the Test-Taking Landscape
- Empowering Parents to Ensure Screen-Free Bedtimes for Kids
- SM Investments Shows Promising Growth with 6% Income Rise
- Steady Growth: SM Investments Corporation's Financial Strength
- Zeekr Group's Impressive Q2 2025 Financial Achievements Revealed
- Euronet International Offers Convertible Senior Notes of $850M
- Eric Trump Discusses Cryptocurrency Adoption After Debanking Events
- Experience Guizhou: A Journey Through Nature’s Masterpiece
- Next Level Performance Unveils a Revolutionary Rewards Marketplace
- Intuitive Machines Enhances Private Offering with $300M Notes
- Inspire Veterinary Sees Remarkable Growth Amid Financial Struggles